Literature DB >> 6819309

Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.

W R Butler, J O Kilburn.   

Abstract

The acid medium required to test susceptibility of Mycobacterium tuberculosis to pyrazinamide (PZA) is a major problem in obtaining reliable test results. Satisfactory growth is usually obtained on Middlebrook and Cohn 7H10 medium at pH 5.5 if albumin-dextrose-catalase (ADC) supplement rather than oleic acid-albumin-dextrose-catalase is used; however, some lots of ADC supplement still fail to support growth at this low pH. A rapid turbidimetric test was developed to determine the growth-supporting potential of ADC enrichment for M. tuberculosis at pH 5.5. An atmosphere supplemented with 5 to 10% carbon dioxide, used to stimulate growth of tubercle bacilli on 7H10 medium, counteracted the growth-inhibiting effects of PZA. By using optimum conditions of medium and pH, the susceptibility of 90% of M. tuberculosis strains to PZA was determined.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819309      PMCID: PMC272548          DOI: 10.1128/jcm.16.6.1106-1109.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Charcoal media for the cultivation of tubercle bacilli.

Authors:  J G HIRSCH
Journal:  Am Rev Tuberc       Date:  1954-12

2.  Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

Authors:  W McDERMOTT; R TOMPSETT
Journal:  Am Rev Tuberc       Date:  1954-10

3.  Growth inhibition of mycobacterium tuberculosis by oleate in acidified medium.

Authors:  R Tummon
Journal:  Med Lab Technol       Date:  1975-07

4.  Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar.

Authors:  K D Stottmeier; R E Beam; G P Kubica
Journal:  Am Rev Respir Dis       Date:  1967-11

Review 5.  Whither short-course chemotherapy?

Authors:  W Fox
Journal:  Br J Dis Chest       Date:  1981-10
  5 in total
  18 in total

1.  Modified method for testing the quality of albumin-containing enrichments used in growth media for mycobacteria.

Authors:  W R Butler; N G Warren; G P Kubica; J O Kilburn
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.

Authors:  Yasuhiko Suzuki; Aya Suzuki; Aki Tamaru; Chihiro Katsukawa; Hajime Oda
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors:  L Heifets; T Sanchez
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.

Authors:  David Pires; Emília Valente; Marta Filipa Simões; Nuno Carmo; Bernard Testa; Luís Constantino; Elsa Anes
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

5.  Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.

Authors:  J Werngren; E Sturegård; P Juréen; K Ängeby; S Hoffner; T Schön
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

6.  Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay.

Authors:  M A Miller; L Thibert; F Desjardins; S H Siddiqi; A Dascal
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity.

Authors:  W R Butler; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

8.  Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.

Authors:  Gaby E Pfyffer; Frantiska Palicova; Sabine Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.

Authors:  M A Miller; L Thibert; F Desjardins; S H Siddiqi; A Dascal
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

10.  Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth.

Authors:  L B Heifets; M D Iseman
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.